Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Proven NSCLC or pulmonary metastases from extra-thoracic primary tumor~* Must be eligible for curative lung resection (lobectomy)~* Tumor/lesion size will be a minimum of 10mm along the minor diameter~* Willing to participate in all aspects of study protocol for duration of the study~* Able to understand study requirements~* Signs informed consent form~Exclusion Criteria:~* Any contraindication to bronchoscopy, for example:~  * Untreatable life-threatening arrhythmias.~ * Inability to adequately oxygenate the patient during the procedure.~ * Acute respiratory failure with hypercapnia (unless the patient is intubated and ventilated).~ * Recent myocardial infarction.~ * Previously diagnosed high-grade tracheal obstruction.~ * Uncorrectable coagulopathy~* Known coagulopathy~* Platelet dysfunction or platelet count \<100 x 10\^3 cells/mm3~* History of major bleeding with bronchoscopy~* Suspected pulmonary hypertension: additional testing required, such as ECG~* Moderate-to-severe pulmonary fibrosis~* Severe emphysema (GOLD III/IV) or chronic obstructive pulmonary disease (COPD):~additional testing and PI consent is required~* Bullae \>5cm located within the same lobe of target tumor/lesion~* Any other severe or life-threatening comorbidity that could increase the risk associated with bronchoscopic RFA~* Ongoing systemic infection~* Contraindications to general anesthesia~* Inability to stop anticoagulants or antiplatelet agents prior to procedure as dictated by the protocol~* Prior thoracic surgery on the same side of the lung as the targeted tumor/lesion~* Breastfeeding women or females of childbearing potential with a positive pregnancy test prior to the procedure or the intent to become pregnant during the study~* Life expectancy of less than one year.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Radio-frequency Ablation (Type: EXPERIMENTAL): Single-arm study where subjects receive radio-frequency ablation prior to a scheduled, surgical resection.

Based on this trial design, predict the completion outcome and termination type (if applicable).